>AFO167 (AFO167Q) /CSM/AF/AFO1-C/AFO167Q.Seq.d/
CACTGTTGGCCTACTGGGATTTTAATAATTTTTTAAATTATAGTAATAAGACAAGAATAT
AAATATTATTCTATAACANTGACAATANACTTTAACTTTAACAATAAACCTAGAATGCAT
TTTTCAACANTACTTAATAATAATAATANAAAATAATAATAATAAAAAAGAATGAAGATG
XXXXXXXXXXATATTTATCAAAAAATCATCCAAAANTCGTTGANCATATTAAAGATAGAG
CATGCTTTAGAAGCAGTTCAACCACAATAACAATCTTTAGCANTANNCTTATATTTTTAA
AGAGAAAAGTGAACCGAATAGAGTGTTCTGCGCCCAGTCTGTAATTTTCATTTAAAGNAA
TGGTGC

llaywdfnnflnysnktri*ilfynxdnxl*l*q*t*naffnxt****XKIIIIKKNED-
--

---YLSKNHPKXVXHIKDRACFRSSSTTITIFSXXLIFLKRKVNRIECSAPSL*fsfkxm
v

Frame A:
hcwptgiliif*iivirqeykyysitxtixfnfnnkprmhfstxlnnnnxk****krmkm
---

---ifikksskxr*xy*r*sml*kqfnhnnnl*xxxyifkeksepnrvfcaqsvifi*xn
g

Frame B:
tvgllgf**ffkl***dkniniil*x*qxtltltinlecifqxyliiiixnnnnkke*r-
--

---YLSKNHPKXVXHIKDRACFRSSSTTITIFSXXLIFLKRKVNRIECSAPSL*fsfkxm
v

Frame C:
llaywdfnnflnysnktri*ilfynxdnxl*l*q*t*naffnxt****XKIIIIKKNED-
--

---iyqkiiqxslxilkiehaleavqpq*qslaxxlyf*rek*te*svlrpvcnfhlkxw
c

                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

AFO167 (AFO167Q) /CSM/AF/AFO1-C/AFO167Q.Seq.d/                        313   1e-84
AFN180 (AFN180Q) /CSM/AF/AFN1-D/AFN180Q.Seq.d/                        188   4e-47
CFJ848 (CFJ848Q) /CSM/CF/CFJ8-B/CFJ848Q.Seq.d/                        184   6e-46
SSH343 (SSH343Q) /CSM/SS/SSH3-B/SSH343Q.Seq.d/                         80   3e-14
VHM715 (VHM715Q) /CSM/VH/VHM7-A/VHM715Q.Seq.d/                         58   1e-07
SFA322 (SFA322Q) /CSM/SF/SFA3-A/SFA322Q.Seq.d/                         50   2e-05
SFI101 (SFI101Q) /CSM/SF/SFI1-A/SFI101Q.Seq.d/                         48   9e-05
SFH777 (SFH777Q) /CSM/SF/SFH7-D/SFH777Q.Seq.d/                         48   9e-05
AFO406 (AFO406Q) /CSM/AF/AFO4-A/AFO406Q.Seq.d/                         48   9e-05
VFM201 (VFM201Q) /CSM/VF/VFM2-A/VFM201Q.Seq.d/                         46   4e-04

                                                               Score     E
Sequences producing significant alignments:                    (bits)  Value  N

BD101624|BD101624.1 Novel genes cloned in humanneuroblastoma and fragments thereof.    50  0.019  1
BD021686|BD021686.1 Novel gene and novel gene fragment cloned in human neuroblastoma.    50  0.019  1
AZ522204|AZ522204.1 203PbG10 Pb MBN #21 Plasmodium berghei genomic 3', DNA sequence.    44  0.14  2
BD097393|BD097393.1 Nucleic acid sequences characterized by their enhanced expression in good prognostic human neuroblastoma upon comparison between good prognostic human neuroblastoma and poor prognostic human neuroblastoma.    36  0.23  3
BD083746|BD083746.1 Nucleic acid sequence characterized in that expression is potentiated in human neuroblastoma with good prognosis, in comparion between human neuroblastoma with good prognosis and human neuroblastoma with bad prognosis.    36  0.23  3
BX220849|BX220849.1 Danio rerio genomic clone DKEY-242E7, genomic survey sequence.    46  0.30  1
AL928835|AL928835.6 Zebrafish DNA sequence from clone CH211-201P7 in linkage group 1.    46  0.59  4
BZ052648|BZ052648.1 jnr20d10.g1 B.oleracea001 Brassica oleracea genomic, DNA sequence.    40  0.61  2
BZ039047|BZ039047.1 lka22d02.g1 B.oleracea002 Brassica oleracea genomic, DNA sequence.    40  0.62  2
BD098880|BD098880.1 Novel genes cloned in humanneuroblastoma and fragments thereof.    42  0.65  2

 ***** No hits found ******

Lambda     K      H
   0.318    0.134    0.401

Gapped
Lambda     K      H
   0.267   0.0410    0.140

Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 3039690
Number of Hits to DB: 323,342,930

 psg: 0.52  gvh: 0.37  alm: 0.45  top: 0.53  tms: 0.00  mit: 0.19  mip: 0.00
 nuc: 0.00  erl: 0.00  erm: 0.00  pox: 0.00  px2: 0.00  vac: 0.00  rnp: 0.00
 act: 0.00  caa: 0.00  yqr: 0.00  tyr: 0.00  leu: 0.00  gpi: 0.00  myr: 0.00
 dna: 0.00  rib: 0.00  bac: 0.00  m1a: 0.00  m1b: 0.00  m2 : 0.00  mNt: 0.00
 m3a: 0.00  m3b: 0.00  m_ : 1.00 

	 40.0 %: nuclear
	 36.0 %: cytoplasmic
	 12.0 %: mitochondrial
	  8.0 %: vacuolar
	  4.0 %: vesicles of secretory system

>> prediction for AFO167 is nuc

>AFO167F.Seq
CACTGTTGGCCTACTGGGATTTTAATAATTTTTTAAATTATAGTAATAAGACAAGAATAT
AAATATTATTCTATAACANTGACAATANACTTTAACTTTAACAATAAACCTAGAATGCAT
TTTTCAACANTACTTAATAATAATAATANAAAATAATAATAATAAAAAAGAATGAAGATG
----------

>AFO167Z.Seq
----------ATATTTATCAAAAAATCATCCAAAANTCGTTGANCATATTAAAGATAGAG
CATGCTTTAGAAGCAGTTCAACCACAATAACAATCTTTAGCANTANNCTTATATTTTTAA
AGAGAAAAGTGAACCGAATAGAGTGTTCTGCGCCCAGTCTGTAATTTTCATTTAAAGNAA
TGGTGC

>AFO167P.Seq
CACTGTTGGCCTACTGGGATTTTAATAATTTTTTAAATTATAGTAATAAGACAAGAATAT
AAATATTATTCTATAACANTGACAATANACTTTAACTTTAACAATAAACCTAGAATGCAT
TTTTCAACANTACTTAATAATAATAATANAAAATAATAATAATAAAAAAGAATGAAGATG
----------ATATTTATCAAAAAATCATCCAAAANTCGTTGANCATATTAAAGATAGAG
CATGCTTTAGAAGCAGTTCAACCACAATAACAATCTTTAGCANTANNCTTATATTTTTAA
AGAGAAAAGTGAACCGAATAGAGTGTTCTGCGCCCAGTCTGTAATTTTCATTTAAAGNAA
TGGTGC